Credit Suisse Upgraded ResMed (RMD) to Neutral Following Q3 Results

Article Stock Quotes (1) Comments (0)

Credit Suisse upgraded ResMed (NYSE: RMD) from Outperform to Neutral Friday morning following the company's Q3 results on Thursday afternoon.

Shares of ResMed are up more than 6 percent at last check.

For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
• Avondale Partners Upgrades United Continental (UAL) to Market Perform
• Morgan Stanley Says Tesla (TSLA) 'Top Pick in U.S. Autos'

Create E-mail Alert Related Categories

Upgrades

Related Entities

Credit Suisse, Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?